Home » Topics » Cardiovascular, BioWorld Science

Cardiovascular, BioWorld Science
RSS

Selective ETA receptor ligands and their use reported by Pfizer scientists

Feb. 23, 2001

Fujisawa discloses inhibitors of NO production

Feb. 23, 2001

Avant reports preliminary results of phase I extension trial for cholesterol management vaccine

Feb. 23, 2001

Vita-Invest's combination therapy for hypertension completes phase III

Feb. 23, 2001

GlaxoSmithKline and Sepsicure establish agreement for sepsis treatment

Feb. 23, 2001

Altace approved in Canada for expanded indication

Feb. 20, 2001

Acute hemodynamic effects and safety of tezosentan in NYHA class III-IV CHF

Feb. 20, 2001

Positive hemodynamic results reported in phase III trial of tezosentan

Feb. 19, 2001

New Aventis compounds block Kv1.5 potassium channels

Feb. 19, 2001

MicroHeart obtains exclusive license to angiogenic/antiinflammatory compound

Feb. 19, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 23, 2026.
To viral or not to viral: In vivo CAR T debates delivery tech
BioWorld
The field of cell and gene therapy is moving toward a new phase of scalability and clinical durability, with in vivo chimeric antigen receptor (CAR) T-cell...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 21, 2026
KBN-2201 reverses key features of Alzheimer’s in mice
BioWorld Science
Researchers from Ajou University School of Medicine reported the preclinical efficacy of KBN-2201 in a mouse model of late-stage Alzheimer’s disease.
In vivo click ADCs could address tumor heterogeneity
BioWorld
Researchers at Washington University in St. Louis have used click chemistry to link a second antibody to a pre-existing antibody-drug conjugate (ADC) in vivo. In...